These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 2464932

  • 1. The impact of MSAFP screening on genetic services, 1984-1986.
    Greenberg F.
    Am J Med Genet; 1988 Sep; 31(1):223-30. PubMed ID: 2464932
    [Abstract] [Full Text] [Related]

  • 2. Maternal serum alpha-fetoprotein screening for Down syndrome: economic considerations.
    Swint JM, Greenberg F.
    Am J Med Genet; 1988 Sep; 31(1):231-45. PubMed ID: 2464933
    [Abstract] [Full Text] [Related]

  • 3. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS, Haverkamp AD, Stark CF, Haverkamp C, Barth CK.
    J Matern Fetal Med; 1996 Sep; 5(2):70-3. PubMed ID: 8796771
    [Abstract] [Full Text] [Related]

  • 4. Abnormal maternal serum alpha fetoprotein and pregnancy outcome.
    Zarzour SJ, Gabert HA, Diket AL, St Amant M, Miller JM.
    J Matern Fetal Med; 1998 Sep; 7(6):304-7. PubMed ID: 9848697
    [Abstract] [Full Text] [Related]

  • 5. [Maternal serum alpha-fetoprotein as a screening test for fetal Down syndrome].
    Bessho T, Kanazawa R, Shiotani T, Mitsuo M, Koyama K.
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Mar; 47(3):237-43. PubMed ID: 7535328
    [Abstract] [Full Text] [Related]

  • 6. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.
    Cheng EY, Luthy DA, Zebelman AM, Williams MA, Lieppman RE, Hickok DE.
    Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967
    [Abstract] [Full Text] [Related]

  • 7. Counseling for low maternal serum alpha-fetoprotein should emphasize all chromosome anomalies, not just Down syndrome.
    Drugan A, Dvorin E, Koppitch FC, Greb A, Krivchenia EL, Evans MI.
    Obstet Gynecol; 1989 Feb; 73(2):271-4. PubMed ID: 2463504
    [Abstract] [Full Text] [Related]

  • 8. Fetal oculocerebrorenal syndrome of Lowe associated with elevated maternal serum and amniotic fluid alpha-fetoprotein levels.
    Miller RC, Wolf EJ, Gould M, Macri CJ, Charnas LR.
    Obstet Gynecol; 1994 Jul; 84(1):77-80. PubMed ID: 7516514
    [Abstract] [Full Text] [Related]

  • 9. [Clinical studies on maternal serum alpha-fetoprotein (MSAFP) of 532 cases--the median value, pregnancy outcomes and clinical evaluation].
    Hayashi M, Kohzu H.
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Oct; 44(10):1211-8. PubMed ID: 1385554
    [Abstract] [Full Text] [Related]

  • 10. Early pregnancy screening for neural tube defects in Israel.
    Legum C, Shomrat R, Yedwab G, Jaffa AJ, Rudick A.
    Isr J Med Sci; 1986 Oct; 22(3-4):210-4. PubMed ID: 2427475
    [Abstract] [Full Text] [Related]

  • 11. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
    Dick PT.
    CMAJ; 1996 Feb 15; 154(4):465-79. PubMed ID: 8630836
    [Abstract] [Full Text] [Related]

  • 12. The relationship between maternal serum alpha-fetoprotein and maternal haemoglobin.
    Bartha JL, Omar KM, Soothill PW.
    Prenat Diagn; 2004 Aug 15; 24(8):609-12. PubMed ID: 15305347
    [Abstract] [Full Text] [Related]

  • 13. Effect of adjustment of maternal serum alpha-fetoprotein levels in insulin-dependent diabetes mellitus.
    Kramer RL, Yaron Y, O'Brien JE, Critchfield G, Ayoub M, Johnson MP, Qualls CR, Evans MI.
    Am J Med Genet; 1998 Jan 13; 75(2):176-8. PubMed ID: 9450880
    [Abstract] [Full Text] [Related]

  • 14. Maternal serum alpha-fetoprotein screening: report of a Canadian pilot project.
    Doran TA, Valentine GH, Wong PY, Wielgosz G, Benzie RJ, Soltan HC, Jenner MR, Morland PA, Montgomery RJ, Allen LC.
    CMAJ; 1987 Aug 15; 137(4):285-93. PubMed ID: 2440547
    [Abstract] [Full Text] [Related]

  • 15. Elevated maternal serum alpha-fetoprotein values. How low is high?
    Lenke RR, Guerrieri J, Nemes JM, Kurczynski TW, French B, Gray M, Schut H, Ashwood ER.
    J Reprod Med; 1989 Aug 15; 34(8):511-6. PubMed ID: 2478705
    [Abstract] [Full Text] [Related]

  • 16. California's experience with low MS-AFP results.
    Lustig L, Clarke S, Cunningham G, Schonberg R, Tompkinson G.
    Am J Med Genet; 1988 Sep 15; 31(1):211-22. PubMed ID: 2464931
    [Abstract] [Full Text] [Related]

  • 17. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
    Mooney RA, Peterson CJ, French CA, Saller DN, Arvan DA.
    Obstet Gynecol; 1994 Aug 15; 84(2):298-303. PubMed ID: 7518896
    [Abstract] [Full Text] [Related]

  • 18. [Serum screening of fetal chromosome abnormality during second pregnancy trimester: results of 26,803 pregnant women in Jiangsu Province].
    Hu YL, Birth Defect Intervention Group of Jiangsu Province.
    Zhonghua Yi Xue Za Zhi; 2007 Sep 18; 87(35):2476-80. PubMed ID: 18067809
    [Abstract] [Full Text] [Related]

  • 19. Effect of normal MSAFP screening on maternal age for genetic amniocentesis.
    Ganiats TG, Berry CC, Fullerton JT.
    J Clin Epidemiol; 1990 Sep 18; 43(11):1143-8. PubMed ID: 1700812
    [Abstract] [Full Text] [Related]

  • 20. Alpha-fetoprotein in obstetrics. Experience of a prenatal diagnosis center.
    Cariati E, Brizzi L, Periti E.
    J Nucl Med Allied Sci; 1989 Sep 18; 33(3 Suppl):72-6. PubMed ID: 2480428
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.